ZBTB16: A Potential Drug Target and Biomarker (G7704)

Target Name: ZBTB16

NCBI ID: G7704

ZBTB16

ZBTB16: A Potential Drug Target and Biomarker

ZBTB16 (ZNF145) is a protein that is expressed in almost all human tissues and is involved in a variety of cellular processes. Its primary function is to regulate the growth and differentiation of tissues, and it has been identified as a potential drug target for a variety of diseases.

The ZNF1 gene encodes the ZNF1 protein, which is a transcription factor that plays a crucial role in the regulation of gene expression. ZNF1 is expressed in a wide range of tissues, including brain, heart, liver, and muscle. It is highly conserved across species, and its sequence is highly conserved between different species.

ZBTB16 is a 16-kDa protein that is expressed in most human tissues. It is highly conserved across species and has a similar structure to ZNF1. ZBTB16 plays a role in the regulation of cellular processes, including cell growth, apoptosis, and stem cell maintenance.

One of the most promising aspects of ZBTB16 is its potential as a drug target. ZBTB16 has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. It is also involved in the regulation of tissue repair and regeneration, which makes it an attractive target for drugs that are designed to promote tissue repair and regeneration.

In addition to its potential as a drug target, ZBTB16 is also a potential biomarker for a variety of diseases. Its expression has been shown to be elevated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This suggests that ZBTB16 may be a useful biomarker for these diseases and could be used in the development of new diagnostic tests.

The identification of ZBTB16 as a potential drug target is based on a number of studies that have shown its involvement in a variety of cellular processes. For example, ZBTB16 has been shown to play a role in the regulation of cell growth and apoptosis, which are processes that are important for the development and progression of many diseases. It is also involved in the regulation of stem cell maintenance and in the development of cancer.

In addition to its involvement in cellular processes, ZBTB16 is also thought to play a role in the regulation of tissue repair and regeneration. This makes it an attractive target for drugs that are designed to promote tissue repair and regeneration, as well as for drugs that are designed to treat diseases that are characterized by the loss of tissue or the failure of the immune system to function properly.

The identification of ZBTB16 as a potential drug target is based on a number of studies that have shown its involvement in a variety of cellular processes. It is highly conserved across species and has a similar structure to ZNF1, which makes it an attractive target for drugs that are designed to mimic the function of ZNF1. The identification of ZBTB16 as a potential drug target and biomarker is a promising development in the field of cancer and other diseases.

Protein Name: Zinc Finger And BTB Domain Containing 16

Functions: Acts as a transcriptional repressor (PubMed:10688654, PubMed:24359566). Transcriptional repression may be mediated through recruitment of histone deacetylases to target promoters (PubMed:10688654). May play a role in myeloid maturation and in the development and/or maintenance of other differentiated tissues. Probable substrate-recognition component of an E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:14528312)

The "ZBTB16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets